Skip to content
Search

Latest Stories

GP appointments could grow by 70 million a year if pharmacies disappear: NPA survey

GP appointments could grow by 70 million a year if pharmacies disappear: NPA survey
pharmacy closures

A substantial, sustained new funding is needed to keep pharmacy doors open and keep pressure off the NHS  

A survey by the National Pharmacy Association (NPA) has highlighted the impact of widespread pharmacy closures in England, which is likely to increase the demand for general practice (GP) appointments by millions.


Over a thousand pharmacies have been closed in England since 2017, with about 10,700 remaining open now.

Currently, GP provides approximately 300 million patient consultations each year, but their demand is set to grow by millions if pharmacies continue to disappear.

In the NPA survey, 64 per cent of UK adults said they would go to their GP more often for advice and treatment if their local pharmacies closed.

A third (34 per cent) of the respondents said they would visit their doctor at least twice more each year, including some who would go on more than 10 extra occasions.

This means there could be between 69 million and 100 million more GP appointments, if all “local” pharmacies in England were to close, the survey suggested.

Nick Kaye, Chair of the NPA, said: “The wait to see your GP or even A&E will inevitably grow if the pharmacy network continues to shrink. Pharmacies currently advise and treat millions of people a year who would otherwise go to their doctor. Patients are the biggest losers from pharmacy closures, having to make longer journeys and waiting longer for treatment, or missing out altogether.

“The government and NHS need to inject substantial, sustained new funding into community pharmacy, to keep pharmacy doors open and keep pressure off other parts of the NHS.”

The associated also cited a 2020 study by Ernst and Young (EY) which predicted that 72 per cent of family-owned pharmacies could be loss making by the end of 2024 if the current funding arrangements remain unchanged.

The Pharmacy First service, which is due to begin across England in late January 2024, is likely to make life easier for patients as well as reduce pressure in the NHS.

The advanced service is designed to improve access to primary care by allowing pharmacists to provide NHS advice and treatments for common ailments like sore throat, shingles and urinary tract infections without the patient needing to visit their GP for a prescription.

Screenshot 2023 12 12 161836

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less